Christoph Deisenhofer
IRBMChristoph Deisenhofer is focusing on the protein biology of fibrosis in the heart and lung using established and novel ex-vivo assay as well as in-vivo models closely resembling human pathology. The goal of this research is to find novel pathways of matrix remodeling as well as understanding communication between the ECM and different cell types in pathology.
For this, he focuses on Immunofluorescence in state of the art imaging such as confocal and multiphoton microscopy. Further, by highly specific pull-down assays we are characterizing the ECM of different disease states using a multitude of proteomic techniques as well as high throughput data analysis.
Christoph has experience in researching heart disease using other model organisms such as danio rerio. Additionally to that, his main research focus is on biophysics and novel treatment methods such as therapeutic antibodies and AAV mediated gene therapy.
Christoph Deisenhofer is focusing on the protein biology of fibrosis in the heart and lung using established and novel ex-vivo assay as well as in-vivo models closely resembling human pathology. The goal of this research is to find novel pathways of matrix remodeling as well as understanding communication between the ECM and different cell types in pathology.
For this, he focuses on Immunofluorescence in state of the art imaging such as confocal and multiphoton microscopy. Further, by highly specific pull-down assays we are characterizing the ECM of different disease states using a multitude of proteomic techniques as well as high throughput data analysis.
Christoph has experience in researching heart disease using other model organisms such as danio rerio. Additionally to that, his main research focus is on biophysics and novel treatment methods such as therapeutic antibodies and AAV mediated gene therapy.